Sarepta Therapeutics (SRPT) Change in Acquisitions & Divestments (2014 - 2026)

Sarepta Therapeutics' Change in Acquisitions & Divestments history runs 13 years deep, the most recent figure standing at $38.9 million for Q1 2026.

• On a quarterly basis, Change in Acquisitions & Divestments fell 4.59% year-over-year to $38.9 million in Q1 2026; TTM through Mar 2026 was $294.0 million, a 81.22% decrease from a year earlier, with the FY2025 full-year figure at $295.9 million, down 85.22% from the prior year.
• Change in Acquisitions & Divestments eased to $38.9 million in Q1 2026 per SRPT's latest filing, from $99.9 million in the prior quarter.
• Across five years, Change in Acquisitions & Divestments topped out at $965.1 million in Q4 2024 and bottomed at $38.9 million in Q1 2026.
• The 5-year median for Change in Acquisitions & Divestments is $348.7 million (2022), against an average of $320.5 million.
• Across the five-year window, Change in Acquisitions & Divestments jumped 1231.9% in 2022 and sank 91.47% in 2025, its largest moves.
• Year by year, Change in Acquisitions & Divestments stood at $446.5 million in 2022, then increased by 18.3% to $528.2 million in 2023, then surged by 82.71% to $965.1 million in 2024, then slumped by 89.65% to $99.9 million in 2025, then plunged by 61.09% to $38.9 million in 2026.
• Per Business Quant, the three latest SRPT Change in Acquisitions & Divestments figures stand at $38.9 million (Q1 2026), $99.9 million (Q4 2025), and $86.6 million (Q3 2025).